LEGACY LABS, LLC – Trademark Portfolio
Entity Type: 16
LEGACY LABS, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include YAY KNAFEH. The owner is based in OLATHE, KS.
18900 SOUTH CLAY BLAIR BLVD
OLATHE, KS 66061
Showing of trademarks Trademarks
Trademark Classifications
LEGACY LABS, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does LEGACY LABS, LLC have?
LEGACY LABS, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned.
What trademark classes does LEGACY LABS, LLC file in?
LEGACY LABS, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LEGACY LABS, LLC's most well-known trademarks?
LEGACY LABS, LLC's registered trademark portfolio includes well-known marks such as YAY KNAFEH. These are among 1 currently registered trademark in the portfolio.
What is LEGACY LABS, LLC's trademark registration success rate?
LEGACY LABS, LLC has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.